The safety and efficacy of the biosimilar anti-CD20 antibody, Truxima, in haematological malignancy

被引：0
|
作者：
Lo, I. [1 ]
Bansal, S. [1 ]
Arami, S. [1 ]
机构：
[1] London Northwest Healthcare NHS Trust, London, England
来源：
LEUKEMIA RESEARCH | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-48
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [31] The effect of anti-CD20 antibody treatment in cynomolgus monkeys
    Park, Hyojun
    Kwon, Yeongbeen
    Lee, Kyo Won
    Park, Jae Berm
    Kim, Sung Joo
    Kim, Kaabsoo
    Lee, Sanghoon
    Lee, Suk Koo
    XENOTRANSPLANTATION, 2015, 22 : S119 - S119
  • [32] Anti-CD20 antibody-related pyoderma gangrenosum
    Reactions Weekly, 2024, 2016 (1) : 2 - 2
  • [33] Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia
    Elsegeiny, Waleed
    Eddens, Taylor
    Chen, Kong
    Kolls, Jay K.
    INFECTION AND IMMUNITY, 2015, 83 (05) : 2043 - 2052
  • [34] Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    Armitage, James O.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14): : 1389 - 1390
  • [35] Anti-CD20 monoclonal antibody therapy in multiple myeloma
    Kapoor, Prashant
    Greipp, Patricia T.
    Morice, William G.
    Rajkumar, S. Vincent
    Witzig, Thomas E.
    Greipp, Philip R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 135 - 148
  • [36] Evolution of anti-CD20 monoclonal antibody therapeutics in oncology
    Oflazoglu, Ezogelin
    Audoly, Laurent P.
    MABS, 2010, 2 (01) : 14 - 19
  • [37] Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis
    Cotchett, Kelly R.
    Dittel, Bonnie N.
    Obeidat, Ahmed Z.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
  • [38] All anti-CD20 monoclonal antibodies have similar efficacy and safety risks: Yes
    Cree, Bruce A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) : 1843 - 1844
  • [39] USE OF BIOSIMILAR ANTI-CD20 (RIXHATON®) IN PATIENTS WITH CORTICORREFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA
    Carbonell, M.
    Garcia, Ortego A.
    Pinzon, Marino S.
    Gomez, Martinez A.
    Hernandez, Mata C.
    Martin-Consuegra, Ramos S.
    Gonzalez, Gomez E.
    Civeira, Marin M.
    Lopez, Pena A.
    Rodriguez, Lefler C.
    Delgado, Beltran P.
    Montanes, Gracia A.
    Recasens, Flores, V
    HAEMATOLOGICA, 2020, 105 : 191 - 192
  • [40] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment
    Davis, TA
    Grillo-López, AJ
    White, CA
    McLaughlin, P
    Czuczman, MS
    Link, BK
    Maloney, DG
    Weaver, RL
    Rosenberg, J
    Levy, R
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3135 - 3143
12345